EVO

Evotec SE

Healthcare · Drug Manufacturers - Specialty & Generic

$174.13 sample

+0.70 (+0.40%) 1D

Market cap

$87.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-02

Alerts

8

Price$174.13 -5.39% 3M daily closessample

188.67167.23

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: EVP, Operations
Oct 08INSInsider buy: Director
Oct 02SECForm 144 filed
Sep 28INSInsider buy: Chief Financial Officer
Sep 23INSInsider buy: General Counsel
Sep 16SEC10-Q filed
Sep 08INSInsider buy: Chief Executive Officer
Sep 01INSInsider sell: General Counsel

Sign up to see the real EVO record →

Company facts

SEC EDGAR registration

Name: Evotec SE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +19sample, -100 to +100
Reporting currency: USD

Who is positioning in EVO

sample

Insiders: 32 insider transactions over 90 days, net selling, $480.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $1.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.1B +14.8% y/y

Q4 2024Q3 2026

Inventory$1.3B +9.0% y/y

Q4 2024Q3 2026

Accounts receivable$918.8M +4.3% y/y

Q4 2024Q3 2026

Total debt$2.5B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $55.6B -12.9% 3M
Sample peer B: $67.3B -13.2% 3M
Sample peer C: $13.8B -3.7% 3M
Sample peer D: $19.6B +9.6% 3M
Sample peer E: $51.6B -4.7% 3M